Infliximab improves skin involvement in psoriatic arthritis regardless of baseline psoriasis severity: Subanalysis of skin response from the IMPACT 2 trial

被引：0
|
作者：
Papp, K
Joshi, S
Guzzo, C
Krueger, G
机构：
[1] Prob Med Res, Waterloo, ON, Canada
[2] Centocor Inc, Malvern, PA 19355 USA
[3] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84112 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：P188 / P188
页数：1
相关论文
共 50 条
  • [1] Infliximab improves psoriasis regardless of arthritis response in patients with active psoriatic arthritis: Results from the IMPACT 2 trial.
    Mease, P
    Kavanaugh, A
    Krueger, GG
    Shergy, W
    Halter, D
    De Vlam, K
    Kirkham, B
    Bala, M
    Beutlers, A
    Guzzo, C
    Zhou, B
    Dooley, L
    Antoni, C
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S616 - S616
  • [2] Infliximab significantly improves joint and skin involvement in psoriatic, arthritis to a substantial extent and irrespective of baseline joint involvement or MTX use: Analysis of clinical response from the IMPACT2 trial
    Kavanauagh, A
    Krueger, GG
    De Vlam, K
    Birbara, C
    Beutler, A
    Guzzo, C
    Zhou, B
    Dooley, L
    Antoni, C
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S617 - S617
  • [3] Infliximab improves arthritis and psoriasis in patients with active polyarticular psoriatic arthritis: Results of the impact 2 trial
    Kavanaugh, A
    Krueger, GG
    De Vlam, K
    Birbara, C
    Beutler, A
    Guzzo, C
    Zhou, B
    DeWoody, K
    Antoni, C
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 402 - 402
  • [4] Adalimumab is efficacious in treating skin disease of psoriatic arthritis patients with mild-to-severe baseline skin involvement: Subanalysis of ADEPT
    Mease, Philip J.
    Gladman, Dafna D.
    Choy, Ernest
    Steinfeld, Serge
    Perdok, Renee
    Okun, Martin M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) : 1819 - 1819
  • [5] Adalimumab is efficacious in treating skin disease in psoriatic arthritis: Subanalysis of moderate versus severe psoriasis in the ADEPT trial
    Gladman, D
    Mease, P
    Kavanaugh, A
    Weinberg, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB10 - AB11
  • [6] Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
    Antoni, C
    Krueger, GG
    de Vlam, K
    Birbara, C
    Beutler, A
    Guzzo, C
    Zhou, B
    Dooley, LT
    Kavanaugh, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) : 1150 - 1157
  • [7] Newly available treatments for psoriatic arthritis and their impact on skin psoriasis
    Galadari, H
    Fuchs, B
    Lebwohl, M
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2003, 42 (03) : 231 - 237
  • [8] The correlation of skin and joint response in patients with psoriatic arthritis treated with infliximab
    Krueger, GG
    Antoni, C
    Bala, M
    Yan, S
    Zhao, N
    Beutler, A
    Guzzo, C
    Kavanaugh, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 319 - +
  • [9] INFLIXIMAB IS EFFECTIVE IN THE TREATMENT OF RESISTANT PSORIATIC ARTHRITIS AND SKIN PSORIASIS: A CLINICAL AND MRI STUDY
    Marzo-Ortega, H.
    Mc Gonagle, D.
    O'Connor, P.
    Conaghan, P. G.
    Greenstein, A. S.
    Tan, A. L.
    Fraser, A.
    Veale, D.
    Emery, P.
    [J]. RHEUMATOLOGY, 2002, 41 : 5 - 5
  • [10] Infliximab results in functional status improvement in patients with active psoriatic arthritis regardless of baseline radiographic damage severity - 1-year results from IMPACT 2
    Kavanaugh, A.
    Krueger, G. G.
    de Vlam, K.
    Birbara, C.
    Beutler, A.
    Zhou, B.
    Dooley, L. T.
    Guzzo, C.
    Bala, M.
    Kirkham, B.
    Antoni, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 418 - 418
12345